dacarbazine and Microsatellite Instability

dacarbazine has been researched along with Microsatellite Instability in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, T; Fujioka, Y; Hata, N; Iwaki, T; Mizoguchi, M; Murata, H; Nakamizo, A; Sasaki, T; Suzuki, SO; Yoshimoto, K	1
Aldape, K; Cahill, DP; Iafrate, AJ; Louis, DN; Miao, J; Nutt, CL; Yip, S	1
Brat, DJ; Burger, PC; Cohen, KJ; Finlay, JL; Gilles, FH; Hamilton, RL; Jakacki, RI; LaFramboise, WA; Lyons-Weiler, MA; Nikiforov, YE; Nikiforova, MN; Pollack, IF; Rosenblum, MK; Sobol, RW; Yates, AJ; Zhou, T	1
Adamson, PC; Berg, SL; Blaney, SM; Delaney, SM; Dolan, ME; Hedge, M; Horton, TM; Ingle, AM; Thompson, PA; Weiss, HL; Wu, MF	1

Trials

1 trial(s) available for dacarbazine and Microsatellite Instability

Article	Year
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Nov-01, Volume: 25, Issue:31 Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Infant; Leukemia; Male; Microsatellite Instability; Neoplasm Recurrence, Local; Temozolomide; Tumor Suppressor Proteins	2007

Article

Year

Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Nov-01, Volume: 25, Issue:31

Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Infant; Leukemia; Male; Microsatellite Instability; Neoplasm Recurrence, Local; Temozolomide; Tumor Suppressor Proteins

2007

Other Studies

3 other study(ies) available for dacarbazine and Microsatellite Instability

Article	Year
Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics. Neuropathology : official journal of the Japanese Society of Neuropathology, 2013, Volume: 33, Issue:6 Topics: Brain Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Microsatellite Instability; Neoplasms, Complex and Mixed; Neurosurgical Procedures; Oligodendroglioma; Phenotype; Temozolomide	2013
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jul-15, Volume: 15, Issue:14 Topics: Antineoplastic Agents, Alkylating; Base Sequence; Blotting, Western; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA Mutational Analysis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glioblastoma; Humans; Microsatellite Instability; Mutation; RNA Interference; Temozolomide; Tumor Cells, Cultured	2009
Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group. Pediatric blood & cancer, 2010, Dec-01, Volume: 55, Issue:6 Topics: Antineoplastic Agents, Alkylating; Child; Dacarbazine; DNA Mismatch Repair; Drug Resistance, Neoplasm; Glioma; Humans; Microsatellite Instability; Microsatellite Repeats; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Temozolomide	2010